Interleukin-21 activates natural killer cell activity against cetuximab-coated pancreatic tumor cells

Lignende værker

• IL-21 enhances natural killer cell response to cetuximab-coated pancreatic tumor cells
  af: McMichael, Elizabeth L., et al.
  Udgivet: (2016)
• Cetuximab Therapy in Head and Neck Cancer: Immune Modulation with Interleukin-12 and Other Natural Killer Cell Activating Cytokines
  af: Luedke, Eric, et al.
  Udgivet: (2012)
• Activation of the FcgammaReceptorIIIa on human natural killer cells leads to increased expression of functional interleukin-21 receptor
  af: Elizabeth L. McMichael, et al.
  Udgivet: (2017-05-01)
• Activation of the FcgammaReceptorIIIa on human natural killer cells leads to increased expression of functional interleukin-21 receptor
  af: McMichael, Elizabeth L., et al.
  Udgivet: (2017)
• Monoclonal Antibody Therapy of Pancreatic Cancer with Cetuximab: Potential for Immune Modulation
  af: Luedke, Eric, et al.
  Udgivet: (2012)